Validation of the 8-week mortality risk model in an independent study group (n = 72; 1980-1989)
| No. of adverse factors . | No. (%) patients . | 8-wk mortality, % . | CR, % . | Survival . | ||
|---|---|---|---|---|---|---|
| Median, mo . | 1-y, % . | 3-y % . | ||||
| 0 | 26 (36) | 23 | 58 | 7 | 35 | 8 |
| 1 | 27 (38) | 52 | 44 | 2 | 7 | 0 |
| 2 | 15 (21) | 60 | 40 | 1 | 7 | 0 |
| ≥ 3 | 4 (6) | 75 | 0 | <1 | 0 | 0 |
| P | .03 | .19 | < .001 | |||
| No. of adverse factors . | No. (%) patients . | 8-wk mortality, % . | CR, % . | Survival . | ||
|---|---|---|---|---|---|---|
| Median, mo . | 1-y, % . | 3-y % . | ||||
| 0 | 26 (36) | 23 | 58 | 7 | 35 | 8 |
| 1 | 27 (38) | 52 | 44 | 2 | 7 | 0 |
| 2 | 15 (21) | 60 | 40 | 1 | 7 | 0 |
| ≥ 3 | 4 (6) | 75 | 0 | <1 | 0 | 0 |
| P | .03 | .19 | < .001 | |||
CR indicates complete response.